Company Overview
Snapshot
Founded in September 2025 by Michael Gavshin, GlucoSonic operates with 1–10 employees. The company is developing an ultrasonic-based sensing technology for non-invasive physiological monitoring, with its primary focus on glucose level measurement. In January 2026, GlucoSonic secured a grant from MIA Dynamics.
Business overview
GlucoSonic is a Health Tech & Life Sciences company focused on developing an ultrasonic-based sensing technology for non-invasive physiological monitoring. Its core product, the GlucoSonic Sensor, is designed for the measurement of glucose levels using acoustic spectroscopy, complemented by compensation algorithms for temperature and sensor distance variations. This hardware and signal-processing platform is intended for integration into medical and consumer monitoring devices, serving global markets across Africa, Europe, the Americas, and Asia.
Company Intelligence Q&A
- What is GlucoSonic's primary technological focus?
- GlucoSonic is developing an ultrasonic-based sensing technology for non-invasive physiological monitoring, specifically targeting glucose level measurement using acoustic spectroscopy.
- When was GlucoSonic founded?
- GlucoSonic was founded in September 2025.
- Who is the founder of GlucoSonic?
- Michael Gavshin is the founder of GlucoSonic.
- What type of product is the GlucoSonic Sensor?
- The GlucoSonic Sensor is a hardware and signal-processing platform designed for potential integration into medical and consumer monitoring devices for non-invasive glucose measurement.
- What was a recent significant development for GlucoSonic?
- In January 2026, GlucoSonic secured a grant from MIA Dynamics.